EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Metabolic Profiling of Brain Tissue and Brain‐Derived Extracellular Vesicles in Alzheimer's Disease

Patricia Hernandez, Elisabeth Rackles, Oihane E Alboniga, Pablo Martínez-Lage, Emma N Camacho, Arantza Onaindia, Manuel Fernandez, Ana Talamillo, Juan M Falcon-Perez iD

Journal of Extracellular Vesicles · 2025

DOI: 10.1002/jev2.70043 ↗

At a glance

Journal article in Journal of Extracellular Vesicles, 2025. Written by Patricia Hernandez and 8 co-authors. Institution: Exosomes Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Sp…. Major MEDLINE topics: Alzheimer Disease, Extracellular Vesicles, Metabolomics, Brain. Cited 20 times so far (Crossref); 109 references. The full text is freely available (open access, CC BY 4.0). Funded by: Alzheimer Association, Deutsche Forschungsgemeinschaft (DFG).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Alzheimer´s disease (AD) is the most frequent neurodegenerative disorder in the world and is characterised by the loss of memory and other cognitive functions. Metabolic changes associated with AD are important players in the development of the disease. However, the mechanism underlying these changes is still unknown. Extracellular vesicles (EVs) are nano‐sized particles that play an important role in regulating pathophysiological processes and are a non‐invasive manner to obtain information of the cell that is secreting them. The analysis of brain‐derived EVs (bdEVs) will provide new insights in the metabolic processes associated with AD. To characterize bdEVs in AD, we optimised a method to isolate them from tissue of different brain regions, obtaining the highest enrichment in isolations from the temporal cortex. We performed unbiased untargeted metabolomics analysis on post‐mortem human temporal cortex tissue and bdEVs from the same region of AD patients and healthy controls. Both, univariate and multivariate statistical analysis were used to determine the metabolites that influence the separation between AD patients and controls. Interestingly, a clear separation between control and AD groups was obtained with bdEVs, which allowed to select 12 relevant features by a validated PLS‐DA model. Furthermore, comparison of tissue and bdEVs identified 68 common features. The pathway enrichment analysis of the common metabolites showed that the alanine, aspartate and glutamate pathway and the arginine, phenylalanine, tyrosine pathway were the most significant ones in the separation between the AD patients and controls. The phenylalanine, tyrosine and tryptophan pathway, still had a very high influence in the separation between groups, albeit not significant. Notably, some metabolites were identified for the first time in bdEVs. For example, the N‐acetyl aspartic acid (NAA) metabolite present in bdEVs was suitable to differentiate AD patients from healthy controls. Furthermore, the analysis of the hippocampus, midbrain, temporal and entorhinal cortex and their respective bdEVs indicated that the metabolic profiles of different brain areas were distinct and showed some correlation between the metabolome of the tissue and its respective bdEVs. Thus, our study highlights the potential of bdEVs to understand the metabolic fingerprint associated with AD and their potential use as diagnostic and therapeutic targets.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseExtracellular VesiclesMetabolomicsBrainMetabolomeHumansMaleFemaleAgedAged, 80 and overTemporal Lobe

Author keywords

Alzheimer's diseasebrainextracellular vesiclesmass spectrometrymetabolomics

Authors and institutions

  • Exosomes Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.
  • Metabolomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.
  • Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Gipuzkoa, Spain.
  • Anatomic Pathology, Araba University Hospital, Vitoria-Gazteiz, Alava, Spain.
  • Bioaraba Health Research Institute, Oncohaematology Research Group, Vitoria-Gasteiz, Spain.
  • Pathology Department, Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain.

ORCID profiles: Juan M Falcon-Perez

Funding

  • Alzheimer Association
  • Deutsche Forschungsgemeinschaft (DFG)

Cite

APA

Hernandez, P., Rackles, E., Alboniga, O. E., Martínez-Lage, P., Camacho, E. N., Onaindia, A., Fernandez, M., Talamillo, A., & Falcon-Perez, J. M. (2025). Metabolic Profiling of Brain Tissue and Brain‐Derived Extracellular Vesicles in Alzheimer's Disease. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70043

Vancouver

Hernandez P, Rackles E, Alboniga OE, Martínez-Lage P, Camacho EN, Onaindia A, et al. Metabolic Profiling of Brain Tissue and Brain‐Derived Extracellular Vesicles in Alzheimer's Disease. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70043

BibTeX
@article{Hernandez2025,
  author = {Hernandez, Patricia and Rackles, Elisabeth and Alboniga, Oihane E and Martínez-Lage, Pablo and Camacho, Emma N and Onaindia, Arantza and Fernandez, Manuel and Talamillo, Ana and Falcon-Perez, Juan M},
  title = {Metabolic Profiling of Brain Tissue and Brain‐Derived Extracellular Vesicles in Alzheimer's Disease},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  doi = {10.1002/jev2.70043}
}
Start for free →